We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$12B
AUM Growth
-$622M
Cap. Flow
-$298M
Cap. Flow %
-2.48%
Top 10 Hldgs %
21.36%
Holding
837
New
28
Increased
81
Reduced
101
Closed
16

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.83K
2
RY icon
Royal Bank of Canada
RY
+$4.09K
3
RIO icon
Rio Tinto
RIO
+$3.61K
4
AMGN icon
Amgen
AMGN
+$3.58K
5
ARW icon
Arrow Electronics
ARW
+$3.22K

Top Sells

Rank Stock Value
1
EDU icon
New Oriental
EDU
+$35.3M
2
TIF
Tiffany & Co.
TIF
+$27.7M
3
VRNS icon
Varonis Systems
VRNS
+$17.6M
4
OSB
Norbord Inc.
OSB
+$16.7M
5
QEP
QEP RESOURCES, INC.
QEP
+$13.7M

Sector Composition

Rank Sector Weight
1 Healthcare 34.23%
2 Technology 22.73%
3 Consumer Discretionary 9.47%
4 Financials 7.93%
5 Communication Services 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APTV icon
751
Aptiv
APTV
$12.3B
$4K ﹤0.01%
32
-11
-26% -$1.6K
MDT icon
752
Medtronic
MDT
$112B
$4K ﹤0.01%
38
+1
+3% +$117
TEL icon
753
TE Connectivity
TEL
$60B
$4K ﹤0.01%
32
+4
+14% +$514
ARW icon
754
Arrow Electronics
ARW
$10.5B
$3K ﹤0.01%
+31
New +$3.22K
BP icon
755
BP
BP
$112B
$3K ﹤0.01%
110
+63
+134% +$1.52K
GSK icon
756
GSK
GSK
$107B
$3K ﹤0.01%
78
+46
+144% +$2.09K
TT icon
757
Trane Technologies
TT
$98.8B
$3K ﹤0.01%
20
-5
-20% -$774
BBL
758
DELISTED
BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares)
BBL
$3K ﹤0.01%
46
+23
+100% +$1.37K
CCK icon
759
Crown Holdings
CCK
$13B
$2K ﹤0.01%
18
– –
ETN icon
760
Eaton
ETN
$141B
$2K ﹤0.01%
17
-5
-23% -$645
NVO
761
Novo Nordisk
NVO
$228B
$2K ﹤0.01%
58
+2
+4% +$71
RVTY icon
762
Revvity
RVTY
$12.6B
$2K ﹤0.01%
+17
New +$2.35K
TEF
763
DELISTED
Telefonica
TEF
$2K ﹤0.01%
610
-12
-2% -$49
WBK
764
DELISTED
Westpac Banking Corporation
WBK
$2K ﹤0.01%
97
+2
+2% +$35
BBVA icon
765
Banco Bilbao Vizcaya Argentaria
BBVA
$142B
$1K ﹤0.01%
120
+5
+4% +$26
BLNK icon
766
Blink Charging
BLNK
$67.5M
$1K ﹤0.01%
+22
New +$959
CRIS icon
767
Curis
CRIS
$9.71M
– –
0
– –
CTMX icon
768
CytomX Therapeutics
CTMX
$690M
$1K ﹤0.01%
+146
New +$1.16K
DAR icon
769
Darling Ingredients
DAR
$9.32B
$1K ﹤0.01%
+19
New +$1.31K
DBX icon
770
Dropbox
DBX
$7.78B
$1K ﹤0.01%
+45
New +$1.08K
DEO icon
771
Diageo
DEO
$49.6B
$1K ﹤0.01%
+8
New +$1.31K
EQNR icon
772
Equinor
EQNR
$97.3B
$1K ﹤0.01%
72
-17
-19% -$323
GRMN
773
Garmin
GRMN
$56.9B
$1K ﹤0.01%
+9
New +$1.12K
ITOS
774
DELISTED
iTeos Therapeutics
ITOS
$1K ﹤0.01%
+18
New +$650
LIN icon
775
Linde
LIN
$236B
$1K ﹤0.01%
+4
New +$1.04K
29 30
31
32 33

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2021 Portfolio in Review

As of Q1 2021, Candriam SCA held 837 positions worth $12B, down 4.9% from $12.6B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2021 filing shows 28 new, 81 increased, 101 reduced and 16 closed positions. Its largest new stake was Arrow Electronics: 31 shares worth $3K. The largest sale was New Oriental, an estimated $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, up from 34% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Candriam SCA's largest Q1 2021 buy was Arrow Electronics: 31 shares worth $3K.
  • Candriam SCA added most to AstraZeneca in Q1 2021, an estimated $5.83K increase.
  • Candriam SCA's biggest Q1 2021 reduction was New Oriental, cutting an estimated $35.3M.
  • Candriam SCA fully exited Tiffany & Co. in Q1 2021, selling an estimated $27.7M.
  • Candriam SCA's ten largest holdings make up 21% of its $12B portfolio in Q1 2021.
  • Candriam SCA opened 28 new positions and closed 16 in Q1 2021.
  • Candriam SCA's portfolio value fell 4.9% quarter-over-quarter to $12B.

Based on Candriam SCA's 13F filing for Q1 2021, filed 29 Apr 2021.